Sunday, November 24, 2024 11/24/2024

ECOG-ACRIN Network Group Operations Center

Award Number: U10CA180820
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Overall: Publicly-funded cancer clinical trials continue to establish new standards of care and improve outcomes for cancer patients. ECOG-ACRIN (EA) has instituted an organizational matrix based on the integration of biological and imaging studies with clinical trials of novel anti-cancer therapies to conduct cutting-edge clinical research and promote scientific discovery. We have incorporated expertise in imaging, cancer biology and therapy within our scientific organization, working closely with the biostatistics and data management centers at the Dana Farber Cancer Institute and Brown University, to propose a research plan that recognizes the importance of biomarkers to bring precisely targeted clinical trials to broad populations of cancer patients. The EA biorepositories, image databases, immunological laboratories, and associated translational science centers will bring together the correlative science studies that relate cancer biology to clinical markers of treatment effect in a data-rich environment. EA embraces the goals and spirit of the NCTN to conduct science-driven clinical trials to improve the lives of adults with cancer. EA clinical trials are implemented through an efficient operational infrastructure that enables access to cutting-edge treatments across the US from large cancer centers to community practices and assures accrual to complex trials in cancers of varying prevalence. Our science is driven by our membership, which includes the NCI-funded Cancer Centers, the Specialized Programs of Research Excellence (SPOREs), the ETCTN (Experimental Therapeutics Clinical Trials Network), the Quantitative Imaging Network (QIN), the NCTN Lead Academic Participating Sites (LAPS), and the National Community Oncology Research Programs (NCORP). As committed participants in the NCTN and in all aspects of CTEP-led cancer research, EA collaborates across the system to promote and advance the collective efforts of all of the groups. We make available the mentorship and opportunity needed to nourish the next generation of investigators. EA is positioned to make unique contributions to the NCTN, working to translate NCI-supported science into improved outcomes for cancer patients. This model, together with developing innovation in large data analysis, will yield high quality trials that have the potential to be practice-changing, applicable to both academic and community environments, and providing imaging and other biomarkers to identify patients who benefit most.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $10,241,815 )
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	11	8/28/2024	NON-COMPETING CONTINUATION	$1,449,750
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	11	3/19/2024	NON-COMPETING CONTINUATION	$0
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	11	3/28/2024	SUPPLEMENT FOR EXPANSION	$804,000
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	11	3/4/2024	NON-COMPETING CONTINUATION	$7,360,793
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	005	11	9/6/2024	NON-COMPETING CONTINUATION	$0
2024	2024	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	11	4/22/2024	NON-COMPETING CONTINUATION	$627,272
														Subtotal = $10,241,815

Issue Date FY: 2023 ( Subtotal = $12,227,070 )
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	10	2/28/2023	NON-COMPETING CONTINUATION	$8,569,357
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	9	1/13/2023	SUPPLEMENT FOR EXPANSION	$452,275
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	005	10	9/8/2023	NON-COMPETING CONTINUATION	$0
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	10	4/3/2023	NON-COMPETING CONTINUATION	$75,000
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	007	10	9/15/2023	SUPPLEMENT FOR EXPANSION	$412,356
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	006	10	9/12/2023	NON-COMPETING CONTINUATION	$1,540,496
2023	2023	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	10	4/12/2023	SUPPLEMENT FOR EXPANSION	$1,177,586
2023	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	9	2/16/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $12,227,070

Issue Date FY: 2022 ( Subtotal = $13,072,476 )
2022	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	9	3/24/2022	NON-COMPETING CONTINUATION	$9,629,743
2022	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	005	9	9/23/2022	NON-COMPETING CONTINUATION	$0
2022	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	9	8/23/2022	NON-COMPETING CONTINUATION	$2,296,540
2022	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	9	4/15/2022	SUPPLEMENT FOR EXPANSION	$1,146,193
2022	2022	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	9	9/16/2022	NON-COMPETING CONTINUATION	$0
2022	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	5	8/29/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $13,072,476

Issue Date FY: 2021 ( Subtotal = $12,637,707 )
2021	2021	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	8	9/17/2021	NON-COMPETING CONTINUATION	$0
2021	2021	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	8	9/10/2021	NON-COMPETING CONTINUATION	$1,091,000
2021	2021	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	8	3/30/2021	SUPPLEMENT FOR EXPANSION	$1,316,230
2021	2021	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	8	2/25/2021	NON-COMPETING CONTINUATION	$9,793,566
2021	2021	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	8	8/20/2021	SUPPLEMENT FOR EXPANSION	$436,911
														Subtotal = $12,637,707

Issue Date FY: 2020 ( Subtotal = $9,278,716 )
2020	2020	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	7	6/3/2020	SUPPLEMENT FOR EXPANSION	$1,199,931
2020	2020	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	7	9/15/2020	NON-COMPETING CONTINUATION	$0
2020	2020	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	7	3/9/2020	NON-COMPETING CONTINUATION	$7,793,785
2020	2020	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	7	9/1/2020	NON-COMPETING CONTINUATION	$285,000
2020	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	6	11/14/2019	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $9,278,716

Issue Date FY: 2019 ( Subtotal = $11,644,145 )
2019	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	005	6	9/20/2019	COMPETING CONTINUATION	$1,030,179
2019	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	6	7/5/2019	COMPETING CONTINUATION	$7,824,801
2019	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	006	6	9/20/2019	SUPPLEMENT FOR EXPANSION	$126,794
2019	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	6	5/31/2019	SUPPLEMENT FOR EXPANSION	$954,907
2019	2019	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	6	3/29/2019	COMPETING CONTINUATION	$9,532,265
2019	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	004	5	7/5/2019	SUPPLEMENT FOR EXPANSION	-$702,581
2019	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	5	7/5/2019	NON-COMPETING CONTINUATION	-$7,122,220
														Subtotal = $11,644,145

Issue Date FY: 2018 ( Subtotal = $12,793,084 )
2018	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	5	3/1/2018	NON-COMPETING CONTINUATION	$9,479,223
2018	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	5	9/14/2018	NON-COMPETING CONTINUATION	$2,611,280
2018	2018	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	5	5/3/2018	SUPPLEMENT FOR EXPANSION	$702,581
2018	2017	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST STE 3000	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	002	4	7/16/2018	NON-COMPETING CONTINUATION	$0
														Subtotal = $12,793,084

Issue Date FY: 2017 ( Subtotal = $11,760,868 ) (Continued on the next page)
2017	2017	ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.	1818 MARKET ST	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	4	4/17/2017	NON-COMPETING CONTINUATION	$140,025
Grand Total All Awards = $135,719,694

Page 1 of 2 (73 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

ECOG-ACRIN Network Group Operations Center

Award Number: U10CA180820

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer